BACKGROUND
Thyroid autoimmunity, or autoimmune thyroid disease, includes a group of disorders that are caused by antibodies that get confused and attack the thyroid. These antibodies are the most common cause of both hyperthyroidism (Graves’ disease) and hypothyroidism (Hashimoto’s thyroiditis). The antibodies can also be present in individuals with normal thyroid function. Thyroid autoimmunity has for many years been considered associated with a poor outcome in women undergoing fertility treatment. As with spontaneous pregnancies, thyroid autoimmunity was associated with a higher pregnancy loss rate and lower live birth rate. However, many initial studies were done in women who were being treated for autoimmune thyroid disease, namely hypothyroidism. Recent studies now question this association in women who have normal thyroid function.
This study investigated the association of thyroid autoimmunity with fertility treatment and live birth rates in a group of infertile women with normal thyroid function and positive thyroid antibodies.
THE FULL ARTICLE TITLE
Rao M et al 2022 Thyroid autoimmunity is not associated with embryo quality or pregnancy outcomes in euthyroid women undergoing assisted reproductive technology in China. Thyroid. Epub 2022 Dec 26. PMID: 36571280.
SUMMARY OF THE STUDY
This was a study of couples undergoing fertility treatment (either in vitro fertilization or intracytoplasmic sperm injection) in a hospital setting in China between 2016 and 2022. All included women had concentrations of serum thyroid function tests within the laboratory reference range prior to treatment. Thyroid autoimmunity was defined as elevated serum thyroid peroxidase antibodies (TPOAbs) or thyroglobulin antibodies (TgAbs).